Actively Recruiting
Role of Cerebroplacental Ratio Discordance at 16-20 Weeks in Predicting Monochorionic Twin Pregnancies' Specific Complications
Led by Ain Shams Maternity Hospital · Updated on 2025-09-05
55
Participants Needed
1
Research Sites
80 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the predictive value of CPR discordance at 16-20 weeks in MCDA twin pregnancies in predicting monochorionic-specific complications such as TTTS, TAPS, sFGR and IUFD of one or both fetuses
CONDITIONS
Official Title
Role of Cerebroplacental Ratio Discordance at 16-20 Weeks in Predicting Monochorionic Twin Pregnancies' Specific Complications
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or more and able to consent.
- Pregnant with monochorionic diamniotic twin pregnancy.
- Have discordant cerebroplacental ratio between twins at 16-20 weeks of gestation.
You will not qualify if you...
- Fetal structural malformations or chromosomal abnormalities in any twin detected antenatally or postnatally.
- Infectious causes identified during pregnancy or postnatal examination.
- Referral after developing twin to twin transfusion syndrome, twin anemia polycythemia sequence, or selective fetal growth restriction.
- Single fetal demise at time of enrollment.
- Conjoint twins.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ain shams maternity hospital
Cairo, Egypt
Actively Recruiting
Research Team
M
Muhammed Ali Hassan, Assistant lecturer
CONTACT
M
Mohamed Sameh Elswaify, Lecturer
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here